Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-15

Clinical Trial Update: Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating celecoxib with radiation therapy for stage II/III soft tissue sarcoma of the limbs after surgical removal; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: University of Miami | Conditions: Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | Phase 1 | Status: COMPLETED